Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

Dr. Peter Weiss, one of the biggest boosters of robotic magnetic navigation, offers his perspective on the needs of EPs and ...

Shares of Stereotaxis advanced after the company said it received Food and Drug Administration approval for its Magnetic Interventional Ablation Catheter product. The stock as up 14% to $2.70 in ...

CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.

Cardiac Electrophysiology Institute Expands Catheter Ablation Access For Los Angeles Heart Rhythm Patients. <a href = target= ...

The heart is at the center of a complex electrical system. Just like any machine, sometimes the system does not always work correctly. There may be a short circuit. This could lead to an abnormal or ...

If medications and lifestyle changes are still not improving your atrial fibrillation symptoms, it may be time to consider a surgical option. Cardiovascular surgeon Jared Bunch, MD, discusses cardiac ...

Medications are the first-line treatment for atrial fibrillation, or A-fib. When they begin to fail, one option is ablation.

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

FDA approval of MAGiC is a significant milestone for Stereotaxis and the community of physicians pioneering robotics in electrophysiology. It ensures the benefits of Robotic Magnetic Navigation can ...

Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...